Manejo clínico del carcinoma oral in situ
Keywords:
carcinoma escamocelular in situ, diagnóstico temprano, cavidad oral, lesiones premalignas, tratamiento quirúrgicoAbstract
Oral squamous cell carcinoma in situ (SCCIS) is a rare premalignant condition with significant implications for early diagnosis and appropriate treatment. This brief review discusses the clinical aspects of SCCIS, highlighting its clinical presentation, differential diagnosis, and the role of biopsies in confirming the diagnosis. A case report is presented of a patient diagnosed with oral SCCIS, detailing the diagnostic approach, surgical treatment, and postoperative progression. The case results emphasize the importance of early detection in preventing progression to invasive squamous cell carcinoma. The review underscores the relevance of early identification of high-risk lesions in the oral cavity to improve patient prognosis.
Downloads
References
Mello FW, Miguel AFP, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra ENS, et al. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis. J Oral Pathol Med. 2018;47(7):633–40.
Woo SB, Cashman EC, Lerman MA. The role of histopathologic diagnosis in the management of oral epithelial dysplasia: A review of the literature. J Oral Pathol Med. 2019;48(9):788–801.
Chamoli R, Alam MS, Siddiqui A, Zaidi I. Molecular markers in oral carcinogenesis: A concise review. J Oral Maxillofac Surg Med Pathol. 2017;29(1):17–23.
Crispino A, Elefante A, Tarsitano A, Marchetti C, Lo Muzio L, Colella G, et al. Oral Microbiome and Oral Cancer: The Importance of a Change. Curr Oncol. 2023;30(2):283.
Bhutia SK, Patra SK. Cancer stem cells in oral cancer: A review. Toxicol Appl Pharmacol. 2023;460:115409.
Scully C, Porter S. Oral cancer. Br Med J. 2000;321(7253):97–100.
INHANCE Consortium. The INHANCE consortium: a resource for genetic epidemiology studies of head and neck cancer. Eur J Epidemiol. 2015;30(11):993– 1001.
Panarese I, Aquino G, Ronchi A, Longo F, Montella M, Cozzolino I, et al. Oral squamous cell carcinoma: from clinical-pathological aspects to molecular biology and immunotherapy. Int J Mol Sci. 2021;22(18):9330.
Badwelan M, Ahmed HG, Rayyan M, Alshareef H, Yaseen A, Alqutub A, et al. Clinicopathological significance and prognostic value of survivin expression in oral squamous cell carcinoma. Diagn Pathol. 2023;18(1):61.
Kaste SC, Hopkins KP, Jenkins JJ, Pratt CB. Imaging of pediatric head and neck tumors. Radiol Clin North Am. 1997;35(4):845–63.
Warnakulasuriya S, Kerr AR. Oral leukoplakia: a review. J Oral Pathol Med. 2021;50(7):655–62.
Mehrotra R, Gupta DK. Exciting prospects in the application of oral cancer biomarkers. J Cancer Res Ther. 2011;7(1):11–21.
Zhao H, Chu M, Huang Z, Yang X, Ran S, Zhang Y, et al. The role of p53 gene and its diagnostic value in oral squamous cell carcinoma. Front Oncol. 2021;11:654256.
Whitmore SE, Lamont RJ. Oral bacteria and cancer. PLoS Pathog. 2014;10(3):e1003933.
Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA. 2007;104(3):973–8.
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jorge Miguel Vallejo-Navas, Gissela Mayli Vaca Rivera, Angelly Gabriela Berrones Gualpa, Karen Vannesa Reinoso Tucunango
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ACCESS AND DISTRIBUTION POLICY
All published articles are open access contributions, which are distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided that the primary source of publication is properly cited.
